BRCA2 and breast carcinoma: In the primary analysis, the hazard ratio (HR) for the association between RRSO and breast cancer risk was 1.23 (95% CI 0.94–1.61) for BRCA1 and 0.88 (95% CI 0.62–1.24) for BRCA2 mutation carriers (Table 3).